• Citer

Longitudinal stability of cerebrospinal fluid biomarker levels: fulfilled requirement for pharmacodynamic markers in Alzheimer's disease.

par Le Bastard, Nathalie;Aerts, Laetitia ;Sleegers, Kristel;Martin, Jean-Jacques ;Van Broeckhoven, Christine;De Deyn, Peter Paul;Engelborghs, Sebastiaan
Référence Journal of Alzheimer's disease, 33, 3, page (807-822)
Publication Publié, 2013

Article révisé par les pairs

• Détails
• Contenu

Titre:	Longitudinal stability of cerebrospinal fluid biomarker levels: fulfilled requirement for pharmacodynamic markers in Alzheimer's disease.
Auteur:	Le Bastard, Nathalie; Aerts, Laetitia; Sleegers, Kristel; Martin, Jean-Jacques; Van Broeckhoven, Christine; De Deyn, Peter Paul; Engelborghs, Sebastiaan
Informations sur la publication:	Journal of Alzheimer's disease, 33, 3, page (807-822)
Statut de publication:	Publié, 2013
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Aged, 80 and over
	Alzheimer Disease -- cerebrospinal fluid -- genetics
	Amyloid beta-Peptides -- cerebrospinal fluid
	Analysis of Variance
	Apolipoproteins E -- genetics
	Cognitive Dysfunction -- cerebrospinal fluid -- genetics
	Female
	Humans
	Longitudinal Studies
	Male
	Mental Status Schedule
	Peptide Fragments -- cerebrospinal fluid
	Phosphorylation
	Spinal Puncture
	Time Factors
	tau Proteins -- cerebrospinal fluid
Langue:	Anglais
Identificateurs:	urn:issn:1387-2877
	info:doi/10.3233/JAD-2012-110029
	info:pii/917231728L987813
	info:pmid/23034521